🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/01/2015 6,80 6,81 6,28 6,32 -8,41% 7,79% 4.165.700
12/01/2015 7,44 7,51 6,51 6,90 -23,84% 13,51% 8.616.600
09/01/2015 7,95 9,33 7,75 9,06 +13,25% 19,87% 7.096.100
08/01/2015 7,44 8,08 7,38 8,00 +8,40% 9,41% 3.777.800
07/01/2015 7,01 7,45 7,01 7,38 +6,11% 6,21% 1.861.000
06/01/2015 7,50 7,75 6,61 6,96 -7,27% 15,20% 3.491.700
05/01/2015 7,69 8,09 7,36 7,50 -2,72% 9,49% 3.809.300
02/01/2015 7,71 7,99 7,49 7,71 +4,47% 6,49% 4.197.100
31/12/2014 7,91 8,15 7,23 7,38 -2,51% 11,63% 4.636.600
30/12/2014 6,58 8,55 6,53 7,57 +14,44% 30,70% 11.695.500
29/12/2014 6,48 6,75 6,48 6,62 +1,46% 4,17% 1.410.900
26/12/2014 6,35 6,61 6,35 6,52 +2,68% 4,09% 796.000
24/12/2014 6,27 6,55 6,20 6,35 +1,20% 5,55% 727.200
23/12/2014 6,57 6,57 6,08 6,28 -4,20% 7,46% 1.758.100
22/12/2014 6,30 6,75 6,11 6,55 +2,50% 10,16% 2.198.200
19/12/2014 6,14 6,40 6,02 6,39 +4,58% 6,19% 4.914.300
18/12/2014 6,12 6,15 5,95 6,11 +0,33% 3,27% 1.456.000
17/12/2014 5,91 6,18 5,80 6,09 +3,92% 6,43% 2.369.400
16/12/2014 5,55 6,19 5,42 5,86 +7,52% 13,87% 2.798.400
15/12/2014 5,77 6,01 5,34 5,45 -5,38% 11,61% 1.857.500
12/12/2014 5,90 6,03 5,63 5,76 -2,87% 6,75% 2.328.600
11/12/2014 5,54 6,07 5,48 5,93 +8,81% 10,65% 3.772.400
10/12/2014 5,65 5,72 5,43 5,45 -4,55% 5,13% 1.507.100
09/12/2014 5,01 5,73 5,00 5,71 +11,20% 14,57% 1.957.000
08/12/2014 5,68 5,71 5,10 5,14 -10,38% 10,74% 1.875.100
05/12/2014 5,07 5,77 4,97 5,73 +14,60% 15,78% 3.584.900
04/12/2014 5,36 5,38 4,95 5,00 -6,54% 7,93% 1.921.900
03/12/2014 5,24 5,39 5,17 5,35 +2,49% 4,10% 1.429.200
02/12/2014 5,41 5,48 5,16 5,22 -3,15% 5,91% 2.189.900
01/12/2014 5,76 5,78 5,32 5,39 -7,39% 7,99% 2.997.100